Research and Development

AstraZeneca has signed an agreement to develop and commercialise a cancer nanomedicine from US firm Bind Therapeutics’ stable of Accurins. …

Biopharma firm Orexigen has announced that its president and chief executive Michael Narachi has been elected to the Board of …

An ABPI meeting on increasing the transparency of the way clinical trials are reported has thrown up more questions than …

The Department of Health has announced that five new members will join the Independent Reconfiguration Panel (IRP) from May. The …

Diganostic firm Venaxis has appointed SomaLogic’s chief medical officer Stephen Williams to the company’s Board of directors.  

Covance has expanded its central laboratory facility in Singapore to meet growing demand for drug development services in the Asia-Pacific …

Eli Lilly and Company has bought a new diagnostic technology which may help point to a different way of treating …

AstraZeneca has signed a new alliance with a UK firm in the field of biomarker discovery.Oxford Cancer Biomarkers is developing …

Teva-Handok has announced the appointment of Yoo Suk Hong as the first chief executive of the business venture between Teva …

Eli Lilly and Co’s new type II diabetes candidate dulaglutide – which it intends to file this year – has …

James Caan, one of the panel of entrepreneurs on TV’s Dragons’ Den, is to expand his business into the healthcare …

A new market of consumer-focused healthcare products is emerging to occupy the space between consumer goods and pharmaceuticals – and …

Aeterna Zentaris has announced that David Dodd has been appointed as its president and chief executive, succeeding Juergen Engel. Dodd …

Celgene has announced the appointment of Karen Browne as business unit director of Haematology, Celgene UK and Ireland. Over the …

Chairman and chief executive of Celgene Robert Hugin has been elected chairman of the Pharmaceutical Research and Manufacturers of America …